AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer
January 21-23, 2022
Hyatt Regency Austin
Timothy Rebbeck, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Sangeeta Bhatia, Massachusetts Institute of Technology, Cambridge, Massachusetts
Luis Alberto Diaz, Jr., Memorial Sloan-Kettering Cancer Center, New York, New York
Ernest T. Hawk, The University of Texas MD Anderson Cancer Center, Houston, Texas
Philip Kantoff, Memorial Sloan-Kettering Cancer Center, New York, New York
Prevention and early detection strategies have great potential to reduce the population burden of cancer. It has been estimated that 50-60% of cancers could be prevented if known strategies were optimally employed. This AACR Special Conference on Precision Prevention, Early Detection, and Interception of Cancer will raise the visibility of advances in the field of prevention and early detection that incorporate biological and mechanistic advances to inspire thinking about new approaches to cancer prevention. The conference will provide a forum for critically reviewing the evidence of the role of biological mechanisms in the cause and progression of cancer, highlighting knowledge of preneoplastic lesions, and new conceptual and technological advances in the field, and outlining the steps required to implement preventive and early detection measures. The program will not only bring together researchers and clinicians from diverse backgrounds to enhance cross-communication but will also spotlight talks from submitted abstracts to highlight the advancements and diversity of the cancer prevention and early detection research field.
Please note that this meeting will take place as an in-person event in Austin and will not live-stream content for virtual participation. The meeting content will be captured and made available as an on-demand program after the meeting. Please see the REGISTRATION page for details.
KEYNOTE SPEAKERS CONFIRMED
Douglas R. Lowy, National Cancer Institute, Bethesda, Maryland
Minetta C. Liu, Mayo Clinic College of Medicine and Science, Rochester, Minnesota